A Corporate Sponsored Research Agreement is a written, legal agreement between an institution (contractor) and an awarding agency normally involving the expectation of an economic benefit on the part of the contractor and the generation of a tangible product, service, or other consideration in return for sponsored support. These might include testing or evaluation of proprietary products, development or construction of equipment, rights to data, patents, copyrights, technical reports or evaluation. Most contracts are Cost-Reimbursement Contracts. Cost-reimbursement contracts provide for payment of allowable incurred costs up to a maximum prescribed in the contract, at which time work should stop unless additional funding is authorized by the agency through a contract modification.
It is the policy of the University to request full funding of indirect costs on all grant and contract proposals. The for-profit indirect cost rates are as follows:
- For-profit sponsors funding basic research (including animal studies), instruction, or other sponsored activities: 40% total direct costs
- For-profit sponsors funding clinical testing (human studies) of drugs or devices (See Clinical Trials): 25% total direct costs (Effective March 1, 2003)
- For-profit sponsors funding short term educational conferences (unrelated to a new or existing project) and outreach programs (may have to be decided on a case by case basis with input from the PI as to how funding came about and how it is related to her/his overall research program): 10% (Effective 1999
The University seeks to promote collaboration with industry where we share research interests. To explore these possibilities, please reach out to Roxana Malene (email@example.com | 773.702.3793) who serves as the URA contact for corporate collaborations; or The Polsky Center, which is responsible for matters involving intellectual property and the licensing of intellectual property.